ORIGINAL RESEARCH

Neurology

doi: 10.25005/2074-0581-2025-27-4-856-863
USING VIRTUAL REALITY EXPOSURE THERAPY IN THE TREATMENT OF SEVERE ANXIETY IN SOMATIC SYMPTOM AND RELATED DISORDERS

A.V. ALTMAN1, E.V. MAZANKINA2, I.G. ТRUKHANOVA3

1Dr. Bobova's Clinic, Samara, Russian Federation
2Department of General and Clinical Psychology, Samara State Medical University, Samara, Russian Federation
3Department of Anesthesiology, Intensive Care and Emergency Medicine, Institute of Vocational Education, Samara State Medical University, Samara, Russian Federation

Objective: To evaluate the impact of virtual reality (VR) breathing training intervention on the level of anxiety, depression, and physiological markers of stress, such as salivary cortisol, in the treatment of severe anxiety in somatic symptom and related disorders (SSRDs)

Methods: : Fifty-eight participants (mean age 37.94±1.9 years) with SSRDs, as classified by DSM-5 and formerly known as somatoform disorders (ICD-10 code F.45), took part in the study. The study participants included 14 men (24.1%) with a mean age of 38.24±1.91 years and 44 women (75.9%) with a mean age of 37.85±1.89 years. To create a VR scene featuring the sky and a receding water surface on the horizon, the Oculus Rift S PC-Powered VR Gaming Headset (Reality Labs division, Menlo Park, CA, USA) was used. Biofeedback-guided breathing training was implemented using the TRsens nasal-oral respiratory temperature sensor and a KARDi2-NP polygraph amplifier (Medical Computer Systems LLC, Moscow, Russia). Participants' emotional states were assessed before the first training session and after the fifth session using the Hamilton Anxiety Rating Scale, the SpielbergerKhanin Rating Scale, and the Hospital Anxiety and Depression Scale (HADS). Salivary cortisol levels were measured before and after the first session, as well as after five sessions.

Results: A positive trend in salivary cortisol levels was observed across the entire study cohort, with a decrease from 6.65 to 5.17 nmol/L (p=0.001). This decrease was also significant when analyzed separately for men, whose levels dropped from 6.44 to 4.87 nmol/L (p<0.001), and women, whose levels decreased from 6.86 to 5.51 nmol/L (p<0.001). Additionally, improvements in patients' emotional states were recorded across all scales before and after five sessions. The results are as follows: Spielberger State Anxiety Scale: Pre-session score was 46.0 [41; 53] and post-session score was 44.0 [38; 52] (p=0.001); Spielberger Trait Anxiety Scale: Pre-session score was 49.5 [43.3; 55.0] and post-session score was 49.0 [41; 52] (p>0.05); Hamilton Anxiety Rating Scale: Pre-session score was 15.0 [4; 18] and post-session score was 11.0 [41; 53] (p=0.002); HADS: Pre-session score was 9.0 [6; 11] and post-session score was 7.0 [5; 9] (p<0.001).

Conclusion: The developed method has shown promise in helping patients respond appropriately to stressful situations. This conclusion is supported by a statistically significant reduction in the emotional exhaustion index, as measured by the study's scales, and a decrease in saliva cortisol levels.

Keywords: Training, virtual reality, biofeedback method, Hamilton scale, Spielberger scale, somatic symptom and related disorders (SSRDs)..

Download file:


References
  1. Aarabi MA, Abdi K, Khanjani MS. Psycho-social consequences associated with COVID-19 in people with ASD and their families: A literature review. Med J Islam Repub Iran. 2021;7(35):131. https://doi.org/10.47176/mjiri.35.131
  2. Deng Y, Chen Y, Zhang B. Different prevalence trend of depression and anxiety among healthcare workers and general public before and after the peak of COVID-19 occurred in China: A meta-analysis. Asian J Psychiatr. 2021;56:102547. https://doi.org/10.1016/j.ajp.2021.102547
  3. Tatayeva R. Psychosomatic aspects of the development of comorbid pathology: A review. Med J Islam Repub Iran. 2022;36:152. https://doi.org/10.47176/ mjiri.36.152
  4. Plana-Ripoll O, Pedersen CB, Agerbo E, Holtz Y, Erlangsen A, Canudas-Romo V, et al. A comprehensive analysis of mortality-related health metrics associated with mental disorders: A nationwide, register-based cohort study. Lancet. 2019;394:1827-35. https://doi.org/10.1016/S0140-6736(19)32316-5
  5. Dubatova IV. Ispolzovanie psikhometricheskikh metodik dlya diagnostiki trevozhno-depressivnykh rasstroystv u patsientov obshchesomaticheskogo profilya [Using psychometric techniques for diagnosing anxiety-depressive disorders in patients with general somatic profile]. Kazanskiy meditsinskiy zhurnal. 2019;100(4):565-70.
  6. Marinova MM. Vliyanie VR-sredy na uroven’ trevozhnosti [The impact of VR environment on anxiety levels]. Eksperimental’naya psikhologiya apparatno-programmnykh kompleksov. 2022;15(2):49-58.
  7. Grekhov RA, Suleymanova GP, Kharchenko SA, Adamovich EI. Psikhofiziologicheskie osnovy primeneniya lechebnogo metoda biologicheskoy obratnoy svyazi [Psychophysiological foundations of the application of the therapeutic method of biological feedback]. Vestnik Volgogradskogo gosudarstvennogo universiteta. 2015;3:87-96.
  8. Imperatori C, Dakanalis A, Farina B, Pallavicini F, Colmegna F, Mantovani F, et al. Global storm of stress-related psychopathological symptoms: A brief overview on the usefulness of virtual reality in facing the mental health impact of COVID-19. Cyberpsychol Behav Soc Netw. 2020;3(11):782-8. https://doi.org/10.1089/ cyber.2020.0339
  9. Kalantari S. Using a nature-based virtual reality environment for improving mood states and cognitive engagement in older adults: A mixed-method feasibility study. Innov Aging. 2022;6(3):igac015. https://doi.org/10.1093/geroni/igac015
  10. Maytner L, Selivanov VV. Kriticheskiy analiz ispol’zovaniya virtual’nykh tekhnologiy v klinicheskoy psikhologii v Evrope (po soderzhaniyu zhurnala «Cyberpsychology, Behavior, and Social Networking») [A critical analysis of the use of virtual technologies in clinical psychology in Europe (based on the content of the journal "Cyberpsychology, Behavior, and Social Networking"]. Sovremennaya zarubezhnaya psikhologiya. 2021;10(2):36-43. https://doi.org/10.17759/ jmfp.2021000001
  11. Marinova MM. Vliyanie sredy virtual’noy real’nosti na uroven’ situativnoy trevozhnosti [The impact of virtual reality environment on the level of situational anxiety]. Psikhologiya kognitivnykh protsessov. 2021;10:65-74.
  12. Selivanov VV, Maytner L, Griber YuA. Osobennosti ispol’zovaniya tekhnologiy virtual’noy real’nosti pri korrektsii i lechenii depressii v klinicheskoy psikhologii [Features of the use of virtual reality technologies in the correction and treatment of depression in clinical psychology]. Klinicheskaya i spetsial’naya psikhologiya. 2021;10(3):231-55. https://doi.org/10.17759/cpse.2021100312
  13. Vicković S, Zdravković R, Maričić-Prijić S, Nikolić D, Pap D, Čolak E, et al. Salivary cortisol as a biomarker of stress in surgical patients. J Med Biochem. 2023;42(3):469-75. https://doi.org/10.5937/jomb0-42011
  14. Nijakowski K, Gruszczyński D, Łaganowski K, Furmańczak J, Brożek A, Nowicki M, et al. Salivary morning cortisol as a potential predictor for high academic stress level in dental students: A preliminary study. Int J Environ Res Public Health. 2022;19(5):3132. https://doi.org/10.3390/ijerph19053132
  15. Huang Z, Yang X, Huang Y, Tang Z, Chen Y, Liu H, et al. Saliva: A new opportunity for fluid biopsy. Clin Chem Lab Med. 2022;61(1):4. https://doi.org/10.1515/cclm2022-0793
  16. Pallavicini F, Orena E, Achille F, Cassa M, Vuolato C, Stefanini S, et al. Psychoeducation on stress and anxiety using virtual reality: A mixed-methods study. Applied Sciences. 2022;12(18):9110. https://doi.org/10.3390/ app12189110
  17. Chaplygin SS, Rovnov SV, Mazankina EV, Berkovich EN, Trukhanova IG, Bobova AV. Sposob relaksatsii i stabilizatsii emotional'nogo sostoyaniya pri pomoshchi virtual'noy real'nosti s ispol'zovaniem metoda biologicheskoy obratnoy svyazi [A method of relaxation and stabilization of the emotional state with the help of virtual reality using the biofeedback method]. Patent Rossiyskoy Federatsii № 2800590 S1. 24.07.2023.

Authors' information:


Altman Alyona Vladimirovna,
Doctor-Therapist at Dr. Bobova's Clinic
ORCID ID: 0000-0003-4823-1652
E-mail: AltmanAV@yandex.ru

Mazankina Elena Vladimirovna,
Senior Lecturer at the Department of General and Clinical Psychology, Samara State Medical University
ORCID ID: 0000-0002-9014-0191
SPIN: 7873-5232
E-mail: e.v.mazankina@samsmu.ru

Trukhanova Inna Georgievna,
Doctor of Medical Sciences, Full Professor, Head of the Department of Anesthesiology, Intensive Care and Emergency Medicine, Institute of Vocational Education, Samara State Medical University
Scopus ID: 56001844900
ORCID ID: 0000-0002-2191-1087
Author ID: 473620
SPIN: 9672-8355
E-mail: innasmp@yandex.ru

Information about support in the form of grants, equipment, medications

The authors did not receive financial support from manufacturers of medicines and medical equipment

Conflicts of interest: No conflict

Address for correspondence:


Altman Alyona Vladimirovna
Doctor-Therapist at Dr. Bobova's Clinic

443056, Russian Federation, Samara, Stara-Zagora str., 25

Tel.: +7 (927) 7333306

E-mail: AltmanAV@yandex.ru


This work is licensed under a Creative Commons Attribution 4.0 International License.

Materials on the topic: